Dronedarone

CAS : 141626-36-0

Ref. 3D-RFA62636

Informations sur le produit

• Nom: Dronedarone
• Synonymes: Methanesulfonamide, N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-, Multaq, N-(2-Butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide, N-(2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide, N-[2-Butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide, N-[2-Butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzo[b]furan-5-yl]methanesulfonamide, N-[2-Butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzofuran-5-yl]methanesulfonamide, Sr 33589, Sr 33589B, Unii-Jqz1L091Y2

Description

Dronedarone is a cardiac antiarrhythmic drug that is used to treat atrial fibrillation and maintain sinus rhythm in patients with chronic heart failure. It belongs to the class of drugs called Class III antiarrhythmics, which are effective for the treatment of both supraventricular and ventricular arrhythmias. Dronedarone has been shown to prolong the duration of the action potential by reducing intracellular calcium levels. This drug also has a negative inotropic effect on myocardial cells, which may be due to its ability to inhibit the inward flow of potassium ions through sodium channels. Dronedarone's effects on cell membrane potentials are mainly due to its inhibition of potassium channels.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 556.76 g/mol
• Formule: C₃₁H₄₄N₂O₅S
• Degré de pureté: Min. 95%